As of December 31, 2023, Mr. Bouthillette held 30,447 RSUs. Such RSUs vested or will vest in three equal installments on February 9, 2024, February 9, 2025 and February 9, 2026.
Restricted Stock
As of December 31, 2023, Mr. Baker held 123,288 shares of restricted stock, which vested or will vest as follows: (i) 48,978 vested on February 1, 2024, (ii) 12,667 vested on February 1, 2024, (iii) 48,977 will vest on February 1, 2025 and (v) 12,666 will vest on February 1, 2025.
As of December 31, 2023, Mr. Lehner held 44,429 shares of restricted stock, which vested or will vest as follows: (i) 15,548 vested on February 1, 2024, (ii) 6,667 vested on February 1, 2024, (iii) 15,548 will vest on February 1, 2025 and (v) 6,666 will vest on February 1, 2025.
As of December 31, 2023, Mr. Bouthillette held 39,765 shares of restricted stock, which vested or will vest as follows: (i) 13,216 vested on February 1, 2024, (ii) 6,667 vested on February 1, 2024, (iii) 13,216 will vest on February 1, 2025 and (v) 6,666 will vest on February 1, 2025.
Employment Agreements
Each of the NEOs entered into employment agreements with KLXE on May 3, 2020, effective as of the effective time of the QES Merger, on substantially similar terms as their prior employment agreements with QES. Each employment agreement generally provides for a three-year term beginning at the effective time of the QES Merger, with automatic renewals for successive one-year periods thereafter. Each employment agreement generally outlines the executive officer’s duties and positions and provides for (i) an annualized base salary, (ii) a target annual bonus equal to 100% of base salary for Mr. Baker, 75% for Mr. Lehner and 75% for Mr. Bouthillette, (iii) eligibility to participate in any equity compensation arrangements or plans offered to senior executives, (iv) an automobile allowance of $1,200 per month and (v) entitlement to benefits made generally available by KLXE to other senior executives.
Each employment agreement provides for the following benefits upon a termination of the executive officer’s employment by KLXE without cause, resignation by the executive officer for good reason, or due to disability: (i) the pro-rata value through the date of termination of the executive officer’s target bonus for the year in which the termination occurs, (ii) a lump sum payment equal to (A) for Mr. Baker, two times Mr. Baker’s base salary or (B) for Messrs. Lehner and Bouthillette, one and one-half times the executive officer’s base salary, (iii) an amount equal to (A) for Mr. Baker, two times Mr. Baker’s target bonus for the year in which the termination occurs or (B) for Messrs. Lehner and Bouthillette, one and one-half times the executive officer’s target bonus for the year in which the termination occurs and (iv) for a period of 18 months following such termination, reimbursement of premiums paid by the executive pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985 to continue coverage in KLXE’s health, dental and vision insurance plans in which the executive and/or his dependents participated immediately prior to the termination (the “COBRA Premium”).
Under each employment agreement, if the executive officer’s employment is terminated for good reason or without cause within 12 months of a change in control, which includes the consummation of the QES Merger, then, in lieu of the severance benefits described in the preceding paragraph, the executive officer will be entitled to receive: (i) the pro-rata value through the date of termination of the executive officer’s target bonus for the year in which the termination occurs, (ii) a lump sum payment equal to (A) for Mr. Baker, two and one-half times Mr. Baker’s base salary or (B) for Messrs. Lehner and Bouthillette, two times the executive officer’s base salary, (iii) an amount equal to (A) for Mr. Baker, two and one-half times Mr. Baker’s target bonus for the year in which the termination occurs or (B) for Messrs. Lehner and Bouthillette, two times the executive officer’s target bonus for the year in which the termination occurs, and (iv) for a period of 18 months following such termination, reimbursement of the COBRA Premium.
29